17-29630850-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001282129.2(SSH2):āc.4344T>Cā(p.Asn1448Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00255 in 1,548,700 control chromosomes in the GnomAD database, including 57 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0097 ( 28 hom., cov: 32)
Exomes š: 0.0018 ( 29 hom. )
Consequence
SSH2
NM_001282129.2 synonymous
NM_001282129.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.529
Genes affected
SSH2 (HGNC:30580): (slingshot protein phosphatase 2) This gene encodes a protein tyrosine phosphatase that plays a key role in the regulation of actin filaments. The encoded protein dephosphorylates and activates cofilin, which promotes actin filament depolymerization. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 17-29630850-A-G is Benign according to our data. Variant chr17-29630850-A-G is described in ClinVar as [Benign]. Clinvar id is 781361.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.529 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00971 (1478/152256) while in subpopulation AFR AF= 0.0312 (1298/41540). AF 95% confidence interval is 0.0298. There are 28 homozygotes in gnomad4. There are 661 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1478 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SSH2 | NM_001282129.2 | c.4344T>C | p.Asn1448Asn | synonymous_variant | 16/16 | ENST00000540801.6 | NP_001269058.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SSH2 | ENST00000540801.6 | c.4344T>C | p.Asn1448Asn | synonymous_variant | 16/16 | 2 | NM_001282129.2 | ENSP00000444743.1 |
Frequencies
GnomAD3 genomes AF: 0.00970 AC: 1476AN: 152138Hom.: 28 Cov.: 32
GnomAD3 genomes
AF:
AC:
1476
AN:
152138
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00371 AC: 775AN: 208998Hom.: 10 AF XY: 0.00291 AC XY: 324AN XY: 111406
GnomAD3 exomes
AF:
AC:
775
AN:
208998
Hom.:
AF XY:
AC XY:
324
AN XY:
111406
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00177 AC: 2474AN: 1396444Hom.: 29 Cov.: 30 AF XY: 0.00165 AC XY: 1132AN XY: 686200
GnomAD4 exome
AF:
AC:
2474
AN:
1396444
Hom.:
Cov.:
30
AF XY:
AC XY:
1132
AN XY:
686200
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00971 AC: 1478AN: 152256Hom.: 28 Cov.: 32 AF XY: 0.00888 AC XY: 661AN XY: 74450
GnomAD4 genome
AF:
AC:
1478
AN:
152256
Hom.:
Cov.:
32
AF XY:
AC XY:
661
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 29, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at